Philip Spear

Philip Spear is an experienced scientist with a diverse background in biotechnology and biomedical research. Currently serving as an SBIR Commercialization Plan Writer at Grant Engine, Philip develops comprehensive plans for grant applications, focusing on technical writing, business plan development, and market analyses. Previous roles include Scientist positions at Solaris Vaccines and Flagship Biosciences, where responsibilities encompassed vaccine prototyping and spatial biology consultation. Philip has also worked as an Imaging Scientist at Biodock, enhancing microscopy analysis through AI, and as a Quality Control Analyst at Novartis Gene Therapies, ensuring compliance in a cGMP environment. Early in the career, Philip held a Senior Scientist position at Greffex, contributing to vaccine development and gene therapy projects. Academic qualifications include a Bachelor of Science in Biology from Truman State University and a Doctorate in Biochemistry, Cell, and Molecular Biology from the University of California, Davis.